Monitoring Intravitreal Injection Patients - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Monitoring Intravitreal Injection Patients

  • By

  • Pamela E. Theriot, OD

  • March 2, 2026

  • 4 min

Share

Objective:

To outline steps for assessing patients for neurotrophic keratitis (NK) following intravitreal injections.

Approach:
    Key Findings:
    • Anti-VEGF injections can cause more corneal damage than other types of intravitreal injections.
    • Early detection of NK is crucial for effective intervention and preventing vision loss.
    • Stage 2 NK shows specific corneal staining patterns and requires careful monitoring.
    Interpretation:

    Regular screening for NK in patients receiving intravitreal injections is essential to improve outcomes and prevent progression to severe stages.

    Limitations:
    • The assessment relies on patient reporting and subjective evaluations.
    • Potential variability in testing methods and interpretation of results.
    Conclusion:

    Proactive monitoring and early intervention for NK in intravitreal injection patients can significantly enhance patient outcomes.

Original Source(s)

Related Content